Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Prostate Cancer (CaP)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

77 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-25

Study Completion Date

2026-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the possibility of patient-centered home care as a new model of cancer care to reduce disparities and improve health related quality of life and patient-reported outcomes in Black patients with prostate cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cleveland African American Prostate Cancer Project

NCT05469269

Prostate Cancer

RECRUITING NA

Facilitating Participation in a Prostate Cancer Risk Assessment Program

NCT02126319

Prostate Cancer

COMPLETED NA

Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy

NCT05872503

Prostate Specific Antigens Positive Digital Rectal Examination Strong Family History of Prostate Cancer +1 more

TERMINATED

Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors

NCT03971591

Prostate Cancer

ACTIVE_NOT_RECRUITING NA

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

NCT03459755

Prostate Cancer

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. To evaluate a highly innovative project evaluating the feasibility of patient-centered home care PCHC as a new model of cancer care to reduce disparities and improve health related QoL (HRQoL) and patient reported-outcomes (PROs) in Black patients with advanced prostate cancer (CaP). (Phase I) II. Establish patient-centeredness by exploring patients' choice relative to the place of CaP treatment for certain aspects of therapy as well as end-of-life care.

III. Establish the acceptance and impact of PCHC on PROs and HRQoL in BM with advanced CaP.

OUTLINE: This is an observational study. Participants are assigned to 1 of 2 groups.

GROUP 1: Participants take part in a focus group or complete questionnaires and may take part in an interview on study.

GROUP 2: Participants complete questionnaires throughout the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Adenocarcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Observational group 1

Participants take part in a focus group or complete questionnaires and may take part in an interview on study.

Non-Interventional Study

Intervention Type OTHER

Non-interventional study

Observational group 2

Participants complete questionnaires throughout the study.

Non-Interventional Study

Intervention Type OTHER

Non-interventional study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional Study

Non-interventional study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* GROUP 1 FOCUS GROUPS:

* Individuals identifying as Black and male who are familiar with the landscape of medical care and cancer
* GROUP 1 SURVEYS:

* Are 18 years of age or older
* Have histologic evidence of prostate adenocarcinoma
* Are requiring, have required, or will require prostate cancer treatment
* Have an understanding of the protocol and its requirements
* Are willing to fill in a questionnaire and participate in a focused interview
* Are able and willing to sign an informed consent
* GROUP 1 INTERVIEWS:

* Enrollment in the survey phase of the protocol
* GROUP 2:

* Are 18 years of age or older
* Are Black men or other discounted patients (older adults, individuals residing in rural or remote areas, and those facing transportation challenges)
* Have histologic evidence of prostate adenocarcinoma
* Are requiring active standard hormone-based therapies (degarelix or leuprolide), antibone resorptive agents (zoledronic acid or denosumab), oral anticancer treatments (abiraterone or second-generation androgen receptor blockers) or intravenous chemotherapy (docetaxel)
* Are receiving part of supportive care/symptom management and/or anti-cancer therapy in the home as part of Cancer Care Beyond Walls (CCBW)
* Have an understanding of the protocol and its requirements
* Are able and willing to sign informed consent

Exclusion Criteria

* GROUP 1 FOCUS GROUPS:

* Individuals who do not identify as Black or male or who have had no extensive interaction with the healthcare system
* GROUP 1 SURVEYS:

* Do not identify as Black men
* Have not been diagnosed with prostate cancer
* GROUP 1 INTERVIEWS:

* Not enrolled in the survey phase of the protocol
* GROUP 2:

* Do not identify as Black men or other discounted patients (older adults, individuals residing in rural or remote areas, and those facing transportation challenges)
* Have not been diagnosed with histologic evidence of prostate adenocarcinoma
* Are not requiring active standard anti-cancer therapy

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes